RT Journal Article
SR Electronic
T1 Cell-based culture of SARS-CoV-2 informs infectivity and safe de-isolation assessments during COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.14.20153981
DO 10.1101/2020.07.14.20153981
A1 Basile, K
A1 McPhie, K
A1 Carter, I
A1 Alderson, S
A1 Rahman, H
A1 Donovan, L
A1 Kumar, S
A1 Tran, T
A1 Ko, D
A1 Sivaruban, T
A1 Ngo, C
A1 Toi, C
A1 O’Sullivan, MV
A1 Sintchenko, V
A1 Chen, S C-A
A1 Maddocks, S
A1 Dwyer, DE
A1 Kok, J
YR 2020
UL http://medrxiv.org/content/early/2020/07/16/2020.07.14.20153981.abstract
AB Background The detection of SARS-CoV-2 by real-time polymerase chain reaction (PCR) in respiratory samples collected from persons recovered from COVID-19 does not necessarily indicate shedding of infective virions. By contrast, the isolation of SARS-CoV-2 using cell-based culture likely indicates infectivity, but there are limited data on the correlation between SARS-CoV-2 culture and PCR. Here we review our experience using SARS-CoV-2 culture to determine infectivity and safe de-isolation of COVID-19 patients.Methods 195 patients with diverse severity of COVID-19 were tested (outpatients [n=178]), inpatients [n=12] and ICU [n=5]). SARS-CoV-2 PCR positive samples were cultured in Vero C1008 cells and inspected daily for cytopathic effect (CPE). SARS-CoV-2-induced CPE was confirmed by PCR of culture supernatant. Where no CPE was documented, PCR was performed on day four to confirm absence of virus replication. Cycle threshold (Ct) values of the day four PCR (Ctculture) and the PCR of the original clinical sample (Ctsample) were compared, and positive cultures were defined as a Ctsample - Ctculture value of ≥3.Findings Of 234 samples collected, 228 (97%) were from the upper respiratory tract. SARS-CoV-2 was only successfully isolated from samples with Ctsample values <32, including in 28/181 (15%), 19/42 (45%) and 9/11 samples (82%) collected from outpatients, inpatients and ICU patients, respectively. The mean duration from symptom onset to culture positivity was 4.5 days (range 0-18 days). SARS-CoV-2 was significantly more likely to be isolated from samples collected from inpatients (p<0.001) and ICU patients (p<0.0001) compared with outpatients, and in samples with lower Ctsample values.Conclusion SARS-CoV-2 culture may be used as a surrogate marker for infectivity and inform de-isolation protocols.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the Prevention Research Support Program funded by the New South Wales Ministry of Health and the National Health and Medical Research Council (APPRISE 1116530). The funders had no role in the study design, data collection, data analysis and interpretation, or writing of the report. The corresponding author had full access to study data and final responsibility for the decision to submit for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Clinical specimens were processed at the NSW Health Pathology-Institute of Clinical Pathology and Medical Research (ICPMR) for standard of care diagnostic purposes and deemed not research. A non-research determination for this project was granted by the Health Protection NSW as it was a designated communicable disease control activity.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData set not attached